BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30535754)

  • 1. Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease.
    Edlinger C; Lichtenauer M; Wernly B; Pistulli R; Paar V; Prodinger C; Krizanic F; Thieme M; Kammler J; Jung C; Hoppe UC; Schulze PC; Kretzschmar D
    Heart Vessels; 2019 Jun; 34(6):976-983. PubMed ID: 30535754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of novel cardiovascular biomarkers in patients with peripheral artery disease.
    Jirak P; Mirna M; Wernly B; Paar V; Thieme M; Betge S; Franz M; Hoppe U; Lauten A; Kammler J; Schulze PC; Lichtenauer M; Kretzschmar D
    Minerva Med; 2018 Dec; 109(6):443-450. PubMed ID: 29652038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of endothelial dysfunction and peripheral arterial disease with sarcopenia in chronic kidney disease.
    Hsu BG; Wang CH; Lai YH; Kuo CH; Lin YL
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1199-1208. PubMed ID: 38644163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease.
    Silvestro A; Scopacasa F; Ruocco A; Oliva G; Schiano V; Zincarelli C; Brevetti G
    Vasc Med; 2003 Nov; 8(4):225-32. PubMed ID: 15125481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher serum levels of soluble intracellular cell adhesion molecule-1 and soluble vascular cell adhesion molecule predict peripheral artery disease in haemodialysis patients.
    Cheng CH; Chen YS; Shu KH; Chang HR; Chou MC
    Nephrology (Carlton); 2012 Nov; 17(8):718-24. PubMed ID: 22905988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin.
    Peter K; Nawroth P; Conradt C; Nordt T; Weiss T; Boehme M; Wunsch A; Allenberg J; Kübler W; Bode C
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):505-12. PubMed ID: 9102169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia.
    Turhan H; Erbay AR; Yasar AS; Aksoy Y; Bicer A; Yetkin G; Yetkin E
    Coron Artery Dis; 2005 Feb; 16(1):45-50. PubMed ID: 15654200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
    Jezovnik MK; Poredos P
    Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events.
    Papayianni A; Alexopoulos E; Giamalis P; Gionanlis L; Belechri AM; Koukoudis P; Memmos D
    Nephrol Dial Transplant; 2002 Mar; 17(3):435-41. PubMed ID: 11865089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations.
    Thakkar V; Patterson KA; Stevens W; Wilson M; Roddy J; Sahhar J; Proudman S; Hissaria P; Nikpour M
    Clin Rheumatol; 2018 Jun; 37(6):1563-1571. PubMed ID: 29687288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease.
    El Eter E; Al Masri A; Habib S; Al Zamil H; Al Hersi A; Al Hussein F; Al Omran M
    Cell Stress Chaperones; 2014 Mar; 19(2):173-81. PubMed ID: 23801458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer's dementia.
    Huang CW; Tsai MH; Chen NC; Chen WH; Lu YT; Lui CC; Chang YT; Chang WN; Chang AY; Chang CC
    Thromb Haemost; 2015 Nov; 114(6):1230-40. PubMed ID: 26289958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
    Meigs JB; Hu FB; Rifai N; Manson JE
    JAMA; 2004 Apr; 291(16):1978-86. PubMed ID: 15113816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis.
    De Caterina R; Basta G; Lazzerini G; Dell'Omo G; Petrucci R; Morale M; Carmassi F; Pedrinelli R
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2646-54. PubMed ID: 9409238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis.
    Brevetti G; Piscione F; Silvestro A; Galasso G; Di Donato A; Oliva G; Scopacasa F; Chiariello M
    Thromb Haemost; 2003 Jun; 89(6):1058-63. PubMed ID: 12783119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of novel cytokines in inflammation: Defining peripheral artery disease among patients with coronary artery disease.
    Ozkaramanli Gur D; Guzel S; Akyuz A; Alpsoy S; Guler N
    Vasc Med; 2018 Oct; 23(5):428-436. PubMed ID: 29638194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction in patients with eosinophilic granulomatosis with polyangiitis.
    Pacholczak R; Bazan-Socha S; Iwaniec T; Zaręba L; Kielczewski S; Walocha JA; Musiał J; Dropiński J
    Clin Rheumatol; 2019 Feb; 38(2):417-424. PubMed ID: 30132147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant coronary and peripheral arterial disease: relationship between the inflammatory status of the affected limb and the severity of coronary artery disease.
    Brevetti G; Piscione F; Schiano V; Galasso G; Scopacasa F; Chiariello M
    J Vasc Surg; 2009 Jun; 49(6):1465-71. PubMed ID: 19497509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.
    Samman Tahhan A; Hayek SS; Sandesara P; Hajjari J; Hammadah M; O'Neal WT; Kelli HM; Alkhoder A; Ghasemzadeh N; Ko YA; Aida H; Gafeer MM; Abdelhadi N; Mohammed KH; Patel K; Arya S; Reiser J; Vaccarino V; Sperling L; Quyyumi A
    Atherosclerosis; 2017 Sep; 264():108-114. PubMed ID: 28728756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study.
    Signorelli SS; Anzaldi M; Libra M; Navolanic PM; Malaponte G; Mangano K; Quattrocchi C; Di Marco R; Fiore V; Neri S
    Angiology; 2016 Oct; 67(9):870-4. PubMed ID: 26888895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.